The Top Line cover image

Teva’s CEO shares ‘Pivot to Growth’ progress

The Top Line

00:00

Innovative Advances in IBD Treatment

This chapter explores groundbreaking developments in a new medicine targeting inflammatory bowel disease, presenting its promising phase two results and market potential. Additionally, it highlights the pharmaceutical company's pipeline assets, collaborations, and emerging oncology treatments, showcasing a commitment to address chronic conditions effectively.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app